6. Literaturverzeichnis

Transkript

1 6. Literaturverzeichnis 1 AGO State of the Art Meeting Gravenbruch 2004.Onkologie 4 (2004) Albain KS, Alled DC, Clark GM: Breast cancer outcome and predictors of outcome. are there age differentials? J Natl Cancer Inst 16 (1994) Albrecht MR, Zink K, Busch W, Rühl U: Axilladissektion oder Axillabestrahlung bei postmenopausalen Patientinnen mit Mammakarzinom? Langzeitergebnisse und Langzeitfolgen bei 655 Patientinnen. Strahlenther Onkol 178 (2002) Ammon J, Aichinger U, Schulz-Wendtland R, Bautz W: V6 Beeinflusst die präoperative Stanzbiopsie das Auftreten von Lokalrezidiven. In: Schreer I, Dietel M (Hrsg): 1.Jahrestagung der Deutschen Gesellschaft für Senologie. ABW Wissenschaftsverlag Berlin 2001, S.7 5 Arbeitsgemeinschaft Gynäkologische Onkologie. AGO-Leitlinien (2004/2005) 6 Bartelink H, Horiot JC, Poortmanns P et al : EORTCRBCG Recurrence rates after tratment of breast cancer with standard radiotherapy or without additional radiation. N. Engl. J Med 345 (2001) Benz J, Juchler A: Mammakarzinom. Lokoregionäres Rezidiv und weiterer Krankheitsverlauf. Helv. chir. Acta 59 (1992) Buchholz TA, Tucker SL, Erwin J et al: Impact of systemic treatment on local control for patients with lymph node-negative breast cancer treated with breastconservation therapy. J Clin Oncol 19 (2001) Carter CL, Allen C, Henson DE et al: Relation of tumor, size, lymph node status, and survival in breast cancer cases. Cancer 63 (1989) Chung M, Chang HR, Bland KI, Wanebo HJ: Younger women with breast carcinoma have a poorer prognosis than older women. Cancer 77 (1996) Clark RM, McCulloch PB, Levine MN et al: Randomized clinical trial to assess the efectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. J Natl Cancer Inst 84 (1992)

2 12 Clark RM, Whelan T, Levine M et al: Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: un update. J Natl Cancer Inst 88 (1996) Delbrück H: Brustkrebs-Rat und Hilfe für Betroffenen und Angehörige. 5. Auflage W. Kohlhammer GmbH, Stuttgart, Berlin, Köln, 2001, S Dunst J: Adjuvante Strahlentherapie beim operablen Mammakarzinom. Onkologe 1 (1995) Dunst J, Steil B, Furch E et al: Prognostic Significance of Recurrence in Breast Cancer after Postmastectomy Radiotherapy. Strahlenther Onkol (2001) EBCTCG-Early Breast Cancer Trialists` Collaborative Group: Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: An overview of the randomised trials. Lancet 355 (2000) Elston CW, Ellis IO: Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long- term follow-up. Histopathology 19 (1991) Engel J, Hölzel D, Kerr J, Schubert G, Fritsch l: Epidemiologie. In: Sauer H (Hrsg.): Manual Mammakarzinome. 9. Auflage. Zuckschwerdt Verlag München, Wien, New York 2003, S Ezzat A, Raja MA, Zwaan F et al: The lack of age as a signifikant prognostic factor in non-metastatic breast cancer. Eur J of Surg Oncol 24 (1998) Fisher B, Anderson S, Redmond CK et al: Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 333 (1995) Fisher B, Anderson S, Bryant J et al: Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347 (2000) Fisher B, Bryant J, Dignam JJ et al: National Surgical Adjuvant Breast and Bowel Projekt: Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancer of one centimeter or less. J Clin Oncol 20 (2002)

3 23 Fitzgibbons PL, Page D, Weaver D et al: Prognostic factors in breast cancer. College American Pathologists Consensus Statement Arch Patholog Lab Med 124 (2000) Forrest AP, Stewart HJ, Everington D et al: Randomised controlled trial of concervation therapy for breast cancer: 6-year analysis of the Scottish Trial. Scottish Cancer Trials Breast Group. Lancet 348 (1996) Fortin A, Larochelle M, Laverdiere J, Lavertu S, Tremblay D: Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radiotherapy. J Clin Oncol 17 (1999) Fowble B, Solin LJ, Schultz DJ, Rubenstein J, Goodman RL: Breast recurrence following conservative surgery and radiation: pattern of failure, prognosis and pathologic findings from mastectomy specimens with implications for treatment. Int J Radiat Oncol Biol Phys 19 (1990) Fredrikson I, Liljegren G, Arnesson LG et al: Local recurrence in the breast after conservative surgery- a study of prognosis and prognostic factors in 391 women. Eur J of Cancer 38 (2002) Freedman G, Fowble B, Hanlon A et al: Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy. Int J Radiat Oncol Biol Phys 44 (1999) Fuentes Raspall MJ, Piedrafita Serra E, Isern Verdum J et al: Locoregional recurrences after conservative treatment of breast cancer stage I-II. Med Clin 118 ( 2002) Furch E: Postoperative Bestrahlung nach Mastektomie und brusterhaltender Operation: Vergleich prognostischer Faktoren und Bedeutung des Lokalrezidivs. Dissertation, Medizinischen Fakultät der Martin-Luther-Universität Halle- Wittenberg, 2003, 70 S 31 Gebauer G, Fehm T, Lang N, Jager W: Tumor size, axillary lymph node status and steroid receptor expression in breast cancer: prognostic relevance 5 years after surgery. Breast Cancer Res Treat (2002)

4 32 Gerber B, Semrau S, Sautter-Bihl ML, Hartmann KA, Fietkau R: Bestrahlung des Mammakarzinoms während der Primärbehandlung. Kein Konsens über optimalen Zeitpunkt der Radiatio. Dt Ärzteblatt 44 (2004) Grabrick DM, Hartmann LC, Cerhan JR et al: Risk of breast cancer with oral contraceptive use in women with family history of breast cancer. JAMA 284 (2000) Hammer J, Mazeron JJ, v Limbergen E: Breast boost - why, how, when...? Streahlenth Oncol 175 (1999) Harbeck N, Thomsson C: Prognosefaktoren und prädiktive Faktoren beim Mammakarzinom. In: Minkwitz v G (Hrsg): Aktuelle Empfehlungen zur Therapie primärer und fortgeschrittener Mammakarzinome. W. Zuckschwerdt Verlag München, Wien, New York, 2002, S Harder F, Laffer U: Brusterhaltene Behandlung des Mammakarzinoms: 10 Fragezeichen. Helv chir Acta 59 (1992) Holli K, Saaristo R, Isola J et al: Lumpectomy with or without postoperative radiotherapy for breast cancer with favourable prognostic features: Results of a randomized study. Br J Cancer 84 (2001) Hölzel D, Engel J, Schmidt M, Sauer H: Sekundäre Metastasierung aus lokoregionalen Rezidiven eines Mammakarzinoms. Strahlenther Onkol 177 (2001) Horiguchi J, Iino Y, Takai H et: Surgical margin and breast recurrence after breast conserving therapy. Oncol Rep 6 (1999) Hortobagyi G: Adjuvant therapy for breast cancer. Annu Rev Med 51 (2000) Huang J, Barbera l, Brouwers M et al: Does delay in starting treatment affect the outcomes of radiotherapy? A systematic rewiew. Clin Oncol 21 (2003) Janni W, Dimpf T, Rjosk D et al: Prognose beim nodalnegativen Mammakarzinom in Abhängigkeit von der Primäroperation - Langzeitergebnisse einer Matched-Pair-Analyse. Geburtsh Frauenheilk 61 ( 2000) Jernström H, Lerman C, Ghaditian P et al: Pregnancy and risk of early breast cancer in carries of BRCA 1 and BRCA2. Lancet 354 (1999)

5 44 Julien JP, Bijker N, Fentiman IS et al: Radiotherapy in breast-conserving treatmant for ductal carcinoma in situ: First results of the EORTC randomised phase III trial EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. Lancet 355 (2000) Kim R, Nishimoto N, Osaki A et al: An analysis of relapsed breast cancer in patients previously treated with breast conserving surgery. Breast cancer 8 (2) (2001) Kim SH, Simkovich-Herdt A, Tran KN et al: Women 35 years of age or younger have higher locoregional relaps rates after undergoing breast conservation therapy. J Am Coll Surg 187 (1998) Kini VR, Vicini FA, Frazier R et al: Mammographic, pathologic and treatmentrelated factors associated with local recurrence in patients with early-stage breast cancer treated with breast conserving therapy. Int J Radiat Oncol Biol Phys 43 (1999) Kodaira T, Fuwa N, Itoh Y et al: Aichi Cancer Center 10-year experience with conservative breast treatment of early breast cancer: Retrospective analysis regarding failure patterns and factors influencing local control. Int J Radiat Oncol Biol Phys 49 (2001) Kreienberg R, Kopp I, Lorenz W, Budach W, Dunst J, Lebeau A, Lück HJ, v. Minckwitz G, Possinger K, Sauerbrei W, Sauerland S, Souchon R, Thomssen C, Untch M, Volm T, Weis J, Schmitt-Reißer B, Koller M, Heilmann V: Interdisziplinäre S3-Leitlinie für die Diagnostik und Therapie des Mammakarzinoms der Frau. Deutsche Krebsgesellschaft e. V. (Hrsg.): W. Zuckschwerdt Verlag München, Wien, New York, 2004, S Kreienberg R, Alt D: Brustkrebs Krankheitsbild und Therapie. In: Kreienberg R, Möbius V, Alt D (Hrsg.): Management des Mammakarzinoms. Springer Verlag Berlin, Heidelberg, New York, 1998 S Kromann Holtveg H, Wohlfart L et al: Effect of breast-conserving therapy versus radical mastectomy on prognosis for young women with breast carcinoma. Cancer 100 (2004) Kuhnt Th, Richter Ch, Enke H, Dunst J: Acute radiation reaction and local control in breast cancer patients treated with postmastectomy radiotherapy. Strahlenther Onkol 174 ( 1998)

6 53 Laffer U, Harder F, Almendral AC et al: Brusterhaltende Therapie beim Mamma- Karzinom: Analyse bei über 1300 in der Region Basel behandelten Patientinnen. Zentralbl Chir 122 (1997) Leitlinie.de; Ärztliches Zentrum für Qualität in der Medizin; Clearingverfahren von BÄK und KBV / Clearingberichte/ Mammaca (2004), mmaca 55 Liljegren G, Holmberg L, Berg J and the Uppsala-Orebro Breast Cancer Study Group: 10-years results after sector resection with or without radiotherapy for stage I breast cancer: A randomized trial. J Clin Oncol 17 (1999) Lind PA, Maeks LB, Jamieson TA et al: Predictors for pneumonitis during locoregional radiotherapy in high-risk patients with breast carcinoma treated with high-dose chemotherapy and stemcell rescue. Cancer 94 (2002) Lindner H, Panzer M, Rottkay v P et al: Radioonkologische Behandlung. In: Sauer H (Hrsg.): Manual Mammakarzinome. 9. Auflage, W. Zuckschwerdt Verlag München, Wien, New York, 2003 S Lüscher NJ: Rekonstruktive Massnahmen beim Lokalrezidiv nach brusterhaltender Therapie des Mammakarzinoms. Helv Chir Acta 59 (1992) Marchbanks PA, MC Donald LA, Wilson HG: Oral contraceptives and risk of breast cancer. N Engl J Med 346 (2002) Marret H, Perrotin F, Bougnoux P et al: Low body mass index is an independent predictive factor of local recurrence after conservative treatment for breast cancer. Breast Cancer Res Treat 66 (2001) Minckwitz v G: Prognostische und prädiktive Faktoren primärer Mammakarzinome. Aktuelle Bestandsaufnahme. Journal Onkologie Mirza Nadeem Q, Vlastors G, Meric F et al: Predictors of locoregional recurrence among patients with early-stage breast cancer treated with breast-conserving therapy. Ann Surg Oncol 9 (2002) Möbus V, Böhm E: Adjuvante Therapie bei Patientinnen unter 35 Jahren. Onkologie 4 (2004)

7 64 Mose S, Adamietz IA, Thilmann C et al: Die Prognose des bilateralen Mammakarzinoms im Vergleich zum unilateralen Mammatumor. Strahlenth Onkol 171 (1995) Müller RP: Strahlentherapie des Mammakarzinoms. In: Kreienberg R, Möbus V, Alt D ( Hrsg.): Managment des Mammakarzinoms. Springer Verlag Berlin, Heidelberg, New York, 1998, S Nestle-Krämling C, Holinski-Feder E, Meindl A, Untch M: Genetik beim Mammakarzinom. Epidemiologie und molekulare Grundlagen. Tumorzentrum München, 14. September (1998) Newman LA, Kuerer HM, Hunt KK et al: Local recurrence and survival among black women with early-stage breast cancer treated with breast-conservation therapy or mastectomy. Ann Surg Oncol 6 (1999) Nitz U, Schütt G: Das Vorgehen bei Patientinnen über 65 Jahre. Onkologie 4 (2004) Overgaard M, Hansen PS, Overgaard J et al: Postoperative radiotherapy in high risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Eng J Med 337 (1997) Park CC, Mitsumori M, Nixon A et al: Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: Influence of margin status and systemic therapy on local recurrence, J Clin Oncol 18 ( 2000) Raab G: Fortschritte in der adjuvanten Therapie des frühen Mammkarzinoms. Onkologie heute 1 (2004) Recht A, Come SE, Henderson RS et al: Sequencing of chemotherapy and radiation therapy after conservative Surgery for early-stage breast cancer. New Engl. J. Med. 334 (1996) Recht A : Impact on outcome of delay in starting radiotherapy. J Clin Oncol 22 (2004)

8 74 Richard F: Chromosomale Imbalancen invasiv duktaler und invasiv lobulärer Mammakarzinome detektiert mittels komparativer genomischer Hybridisierung (CGH). Berlin, Univ Diss 1999, 60 S 75 Romestaing P, Lehingue Y, Carrie C et al: Role of a 10Gy boost in the conservative tratment of early breast cancer: Results of a randomized clinical trial. Lyon, France. J Clin Oncol 15 (1997) Ronay G, Sponsel N, Merkle E, Tulusan AH: Progesteron-Rezeptoren beim Mammakarzinom: Vergleich der immunhistochemischen mit der biochemischen Rezeptoranalyse. Beziehungen zwischen Hormonrezeptorgehalt und Wachstumsfaktoren. Pathologe 11 (1990) Sauer H, Artmann A, de Waal JC et al: Nachsorge. In: Sauer H (Hrsg.):Manual Mammakarzinome. 9. Auflage, W. Zuckschwerdt Verlag München, Wien, New York, 2003, S Sauer R, Schauer A, Rauschecker HF et al: Therapy of small breast cancer: A prospective study on 1036 patients with special emphasis on prognostic factors. Int J Radiat Oncol Biol Phys 23 (1992) Scharl A: Adjuvante hormonelle Therapie in der Prämenopause. In: Minckwitz v G (Hrsg.): Aktuelle Empfehlungen zur Therapie primärer und fortgeschrittener Mammkarzinome. W. Zuckschwerdt Verlag München, Wien, New York, 2002, S Schmoor C, Sauerbrei W, Bastert G, Schumacher M: Role of isolated locoregional recurrence of breast cancer: Results of four prospective studies. J Clin Oncol 18 (2000) Seegenschmiedt MH: Strahlentherapie beim lokalisierten Mammakarzinom. In: Minckwitz v. G (Hrsg.): Aktuelle Empfehlungen zur Therapie primärer und fortgeschrittener Mammakarzinome. W. Zuckschwerdt Verlag München, Wien, New York, 2002, S Simon WE: Lokoregionäres Rezidiv. In: Minckwitz v G (Hrsg): Aktuelle Empfehlungen zur Therapie primärer und fortgeschrittener Mammakarzinome. W. Zuckschwerdt Verlag München, Wien, New York, 2002 S

9 83 Solin LJ, Fourquet A Vicini FA et al : Salvage treatment for local recurrence after breast-conserving surgery and radiation as initial treatment for mammograghically detected ductal carcinoma in situ of the breast. Cancer 91 (2001) Steil B: Ergebnisse der Strahlentherapie des Mammakarzinoms nach Mastektomie - Eine retrospektive Analyse der Jahre Dissertation der Medizinischen Fakultät der Martin-Luther-Universität Halle-Wittenberg, 2000, 65 S 85 Stotter AT, McNeese MD, Ames FC et al: Predicting the rate and extent of locoregional failure after breast conservation therapy for early breast cancer. Cancer 64 (1989) Stierli P, Spichtig S, Aeberhard P: Brusterhaltende Therapie des Mammakarzinoms: Sensitivität der Mammographie bezüglich Primärtumorgrösse. Helv chir Acta 59 (1992) Swanson GP, Rynearson K, Geyer E jr, Symmonds R, Hardin W: Breast conservation in the treatment of breast cancer: Community-based experience. South Med J 94 (2001) Swenson KK, Decher L, Haselow R, Farrell JB, Sperduto PW: Prognostic factors after conservative surgery and radiation therapy for early stage breast cancer. Am J Clin Oncol 21 (1998) Tienhoven vg, Voogd AC, Peterse JL et al: Prognosis after treatment for locoregional recurrence after mastectomy or breast conserving therapy in two randomised trials ( EORTC and DBCG-82 TM). E J Cancer 35 (1999) Veronesi U, Marubini E, Mariani L et al: Radiotherapy after breast-conserving surgery in small breast carcinoma. Long-terms results of a randomised trial. Ann Onkol 12 (2001) Veronesi U, Marubini E, Del Vecchio M et al: Local recurrence and distant metastases after conservative breast cancer treatments: Partly independant events. J Natl Cancer Inst 87 (1995) Veronesi U, Zucali R,Luini A(1986) Local control and survival in early breast cancer:the Milan trial. Int J Radiat Onol Biol Phys 12 (1986)

10 93 Vinh-Hung V, Verschraegen C: Breast-conserving surgery with or without radiotherapy; pooled analysis for risks ofiipsilateral breast tumor recurrence and mortality. J of Nat Cancer 96 (2004) Voogd AC, Nielson M, Peterse JL et al: Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomizid trials. J Clin Oncol 19 (2001) Voogd AC, Thienhoven v G, Perterse HL et al: Local recurrence after breast conservation therapy for erly stage breast carcinoma. Dutch Study Group on Local Recurrence after Breast Conservation. Cancer 85 (1999) Vujovic O, Perera F, Dar AR et al: Does delay in breast irradiation following conservative breast surgery in node-negative breast cancer patients have an impact on risk of recurrence? Int J Radiat oncol Biol Phys 40 (1998) Walker RA, Lees E, Webb MB, Dearing SJ: Breast carcinomas occuring in young women (<35 years) are different. Br J Cancer 74 (1996) Walther E, Hünig R, Harder F et al: Diagnostische Probleme beim Lokalrezidiv nach brusterhaltender Behandlung. Helv chir Acta 59 (1992) Welz St, Bamberg M, Budach W: Strahlentherapie in den verschiedenen Stadien. Onkologie 4 (2004) Würschmidt F, Willers H, Janik I, Bünemann H, Heilmann HP: Kombinierte brusterhaltende Chirurgie, Chemotherapie und Strahlentherapie bei der Behandlung des Mammakarzinoms. Der Einfluß des Intervalls zwischen Operation und Bestrahlungsbeginn. Strahlenther Onkol 173 (1997) Yaghan R, Stanton PD, Robertson KW et al: Oestrogen receptor status predicts local recurrence following breast conservation surgery for early breast cancer. Eur J Surg Oncol 24 (1998)